D-368-2014 Class II Terminated
FDA drug recall D-368-2014 was initiated by Baxter Healthcare Corp. on Nov 12, 2013 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; Drug product leaking from container therefore sterility cannot be assured The recall status is terminated (terminated Jun 10, 2015). Affected quantity: 14,622 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 25, 2013
- Initiation Date
- Nov 12, 2013
- Termination Date
- Jun 10, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,622 bags
Product Description
10%, Travasol (Amino Acid) Injection, 2000 ml, Pharmacy Bulk Package Not for Direct Infusion, Baxter Healthcare Corporation, Clintec Nutrition Division, Deerfield IL 60015 USA. NDC: 0338-0644-06.
Reason for Recall
Lack of Assurance of Sterility; Drug product leaking from container therefore sterility cannot be assured
Distribution Pattern
Nationwide
Code Information
Lot: P302646, Exp 5/31/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-368-2014
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026